BRCA1 Intragenic Duplication Combined with a Likely Pathogenic TP53 Variant in a Patient with Triple-Negative Breast Cancer: Clinical Risk and Management
International Journal of Molecular Sciences(2024)
Key words
hereditary breast and ovarian cancer syndrome (HBOC),multi-gene panel testing,double heterozygotes,genetic counseling,exon duplication
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined